Haemonetics combines Plasma and Blood Center units into new Apheresis reporting segment
Haemonetics Corporation
Haemonetics Corporation HAE | 0.00 |
- Haemonetics reorganized financial reporting into two segments from three, combining Plasma and Blood Center into Apheresis.
- Hospital segment renamed MedSurg to better match internal management and resource allocation.
- New structure takes effect with Q1 fiscal 2027, which began March 29, 2026.
- Supplemental revenue disclosure continues, splitting Apheresis into Plasma and Other, MedSurg into Blood Management Technologies and Interventional Technologies.
- Historical quarterly revenue for fiscal 2024-2026 recast for comparability; fiscal 2027 revenue guidance also recast without updating prior guidance.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606050630PR_NEWS_USPR_____NE76713) on June 05, 2026, and is solely responsible for the information contained therein.
